Search results for: 'document management systems'

The process analytical instrumentation market includes analyzers that are plugged in as part of the industrial process and provide real-time measurements. Process analytical Instrumentation consists of four segments: process gas chromatographs, spectrometers, and gas and liquid analyzers. Process gas chromatography is the most widely used analysi...

Leading participants in the global bioplastics market are developing high-performance and sustainable products from bio-based derivatives. As more and more companies focus on reducing their dependence on crude oil and reducing the amount of waste in landfills and oceans, end-user industries are seeking cost-effective bio-based alternatives for pack...

The Internet of Things (IoT) is a complex ecosystem that integrates Information Technology (IT) with Operational Technology (OT) to generate data that can be analysed to increase revenues and improve business productivity. The IoT has moved from the machine-to-machine (M2M) era in which monitoring an asset was the main objective to sensing, gatheri...

The Asia-Pacific hosted Internet protocol (IP) telephony and unified communications-as-a-service (UCaaS) market is experiencing dynamic growth caused by a surge in demand for cloud-based communications platforms. As industries gradually evolve in the digital economy, enterprises are embracing UCaaS to capitalize on the benefits of cloud-based servi...

23 Dec 2020  |  South Asia, Middle East & North Africa  |  Frost Radar

Frost Radar™: Indian Passenger and Commercial Vehicle Tyre Market, 2020

A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

The Indian automotive tyre market is one of the largest in the world. Its value was estimated at $8,081 million as of FY20, including the original equipment (OE) supply, aftermarket, and exports. The passenger vehicle (PV) and commercial vehicle (CV) tyre segments together contribute almost 40% to the overall volume. These two segments are the bigg...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

23 Nov 2021  |  North America  |  Frost Radar

Frost Radar™: US Long-haul Autonomous Trucking Technology Companies, 2021

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The trucking industry is plagued by driver shortages, higher vehicle prices, fuel price volatility, safety concerns, and performance limitations amid rapidly transforming freight handling, stocking, and distribution practices. Autonomous driving technologies would help to address some of these challenges by providing a cost-effective and safe m...

14 Dec 2021  |  Global  |  Frost Radar

Frost Radar™: Global Off-Highway Autonomous Technology Market, 2021

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The promise of worker safety and productivity gains will drive the development of autonomous off-highway equipment in the medium-to-long term. Unmanned equipment’s ability to operate 24/7 without interference enables easier integration of technology into existing infrastructure and fleets, which will boost interest in this market. Even though th...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...